WHO ICTRP trial
To see the effect of 2 medicines namely panchasama churna and kshara basti in…
CTRI/2022/04/042053 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/04/042053 |
|---|---|
| Public title | To see the effect of 2 medicines namely panchasama churna and kshara basti in the treatment of disease Amavata(Rheumatoid Arthritis)Â |
| Scientific title | A Randomized Comparative Clinical Study To Evaluate The Efficacy Of Panchsamachurna And Ksharbasti In The Management Of Amavata W.S.R. To Rheumatoid Arthritis |
| Primary sponsor | Ayurvedic and Unani Tibbia College Hospital |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: M05- Rheumatoid arthritis with rheumatoid factor |
| Registration date | Apr 21, 2022 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: